Danaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.
Follow DHR
Danaher Corporation (DHR) Revenue growth
Danaher Corporation's revenue growth over the twelve months to 30 June 2026 was 4.56%, up 1.7 percentage points from fiscal 2025 (2.90%). Over the past ten years it has ranged from −10.3% (fiscal 2023) to 24.4% (fiscal 2020); the current reading is higher than 36% of that period. That is below the Diagnostics & Research industry median of 7.69% and below the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 2.90% | 2.96 |
| FY2024 | −0.06% | 10.27 |
| FY2023 | −10.3% | (17.75) |
| FY2022 | 7.42% | (3.88) |
| FY2021 | 11.3% | (13.12) |
| FY2020 | 24.4% | 19.36 |
| FY2019 | 5.06% | (4.80) |
| FY2018 | 9.86% | 17.94 |
| FY2017 | −8.08% | (25.05) |
| FY2016 | 17.0% | 4.79 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 5.54% | 1.88 |
| Mar 2026 | 3.66% | (0.93) |
| Dec 2025 | 4.59% | 0.19 |
| Sep 2025 | 4.40% | 1.04 |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| WAT Waters Corporation compare | 52.5% |
| NTRA Natera, Inc. compare | 37.8% |
| IDXX IDEXX Laboratories, Inc. compare | 12.8% |
| A Agilent Technologies, Inc. compare | 8.60% |
| IQV IQVIA Holdings Inc. compare | 8.17% |
| TMO Thermo Fisher Scientific Inc. compare | 7.23% |
| MTD Mettler-Toledo International, Inc. compare | 6.91% |
| ILMN Illumina, Inc. compare | 4.88% |
| DHR Danaher Corporation | 4.56% |
| Diagnostics & Research industry median | 7.69% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on DHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement